Real-time enrollment status for this relapsing multiple sclerosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT06433752 |
| Recruiting Status | Recruiting |
| Condition | Relapsing Multiple Sclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 2,000 participants |
| Active Locations | 89 sites in the US |
| Sponsor | TG Therapeutics, Inc. |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06433752 is currently recruiting participants. This clinical trial study for relapsing multiple sclerosis is actively seeking new participants at 89 locations across the United States. The study is sponsored by TG Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06433752 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 89 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06433752 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.